Company Description
Apollo Endosurge (NASDAQ: APEN) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $579.7M.
APEN stock has gained 71.5% over the past year.
This page provides a comprehensive overview of APEN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Apollo Endosurge (APEN) stock. Over the past 12 months, the stock has gained 71.5%. At a market capitalization of $579.7M, APEN is classified as a small-cap stock with approximately 58.0M shares outstanding.
Latest News
Apollo Endosurge has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings, acquisition, conferences. View all APEN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
APEN Company Profile & Sector Positioning
Apollo Endosurge (APEN) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing APEN often look at related companies in the same sector, including Orthofix Med Inc (OFIX), Avanos Medical (AVNS), ZIMVIE INC (ZIMV), Cytek Biosciences, Inc. (CTKB), and Orthopedia (KIDS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate APEN's relative position within its industry.